X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-07-24 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.06 | -7,772 | 0 | -100% | -$140,360 | |||||
| D | 2024-07-18 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.20 | -12,625 | 0 | -100% | -$229,804 | |||||
| DM | 2024-07-12 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.02 | -9,189 | 0 | -100% | -$165,578 | |||||
| DM | 2024-07-01 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.01 | -912 | 0 | -100% | -$16,428 | |||||
| D | 2024-06-24 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.19 | -9,260 | 0 | -100% | -$168,427 | |||||
| DM | 2024-06-11 | PEPG | Mellion Michelle L | Chief Medical Officer | S - Sale+OE | $18.06 | -1,586 | 0 | -100% | -$28,637 | |||||
| DM | 2024-06-05 | PEPG | Mellion Michelle L | SVP, Clinical Development | S - Sale+OE | $18.08 | -8,656 | 0 | -100% | -$156,460 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |